Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.60
+2.76 (9.25%)
At close: Oct 20, 2026, 4:00 PM EDT
33.19
+0.59 (1.81%)
Pre-market: Oct 21, 2026, 4:01 AM EDT
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.68 billion as of October 20, 2026. It is the 7,455th most valuable company in the world and the 1,890th biggest in the United States. Its market cap has decreased by 0.72% in one year.
Market Cap
1.68B
Enterprise Value
1.23B
1-Year Change
-0.72%
Global Rank
Country Rank
#1,890 United States
Category
ChartMarket Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.68B, a decrease of -6.52%. That is a compound annual growth rate of -1.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 1.68B | -4.28% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nuvation Bio | 1.56B |
| Stoke Therapeutics | 1.56B |
| Generate Biomedicines | 1.55B |
| Maze Therapeutics | 1.53B |
| Braveheart Bio | 1.53B |
| uniQure | 1.51B |
| Ocular Therapeutix | 1.51B |
| Structure Therapeutics | 1.50B |